Crosstalk Between Platelets and Microbial Pathogens

Front Immunol. 2020 Aug 7:11:1962. doi: 10.3389/fimmu.2020.01962. eCollection 2020.

Abstract

Platelets, small anucleate cells circulating in the blood, are critical mediators in haemostasis and thrombosis. Interestingly, recent studies demonstrated that platelets contain both pro-inflammatory and anti-inflammatory molecules, equipping platelets with immunoregulatory function in both innate and adaptive immunity. In the context of infectious diseases, platelets are involved in early detection of invading microorganisms and are actively recruited to sites of infection. Platelets exert their effects on microbial pathogens either by direct binding to eliminate or restrict dissemination, or by shaping the subsequent host immune response. Reciprocally, many invading microbial pathogens can directly or indirectly target host platelets, altering platelet count or/and function. In addition, microbial pathogens can impact the host auto- and alloimmune responses to platelet antigens in several immune-mediated diseases, such as immune thrombocytopenia, and fetal and neonatal alloimmune thrombocytopenia. In this review, we discuss the mechanisms that contribute to the bidirectional interactions between platelets and various microbial pathogens, and how these interactions hold relevant implications in the pathogenesis of many infectious diseases. The knowledge obtained from "well-studied" microbes may also help us understand the pathogenesis of emerging microbes, such as SARS-CoV-2 coronavirus.

Keywords: COVID-19; host immune responses; microbial pathogens; platelets; thrombosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adaptive Immunity
  • Betacoronavirus*
  • Blood Platelets / immunology*
  • Blood Platelets / metabolism*
  • COVID-19
  • Coronavirus Infections / immunology*
  • Coronavirus Infections / virology
  • Hemostasis
  • Host-Pathogen Interactions / immunology*
  • Humans
  • Immunity, Innate
  • Inflammation / immunology
  • Pandemics
  • Pneumonia, Viral / immunology*
  • Pneumonia, Viral / virology
  • SARS-CoV-2
  • Thrombosis / metabolism

Grants and funding